These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6152347)

  • 1. Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics.
    Wood PL; McQuade PS
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):773-7. PubMed ID: 6152347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive changes of the striatal dopamine system induced by repeated administration of neuroleptics and ergot derivatives.
    Bürki HR
    Adv Biochem Psychopharmacol; 1980; 24():65-8. PubMed ID: 6105806
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
    Guinetdinov RR; Bogdanov MB; Pogorelov VM; Kudrin VS; Rayevsky KS
    Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J; Sebens JB
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo 3H-spiroperidol binding to rat striatum and the inhibitory effects of neuroleptics.
    Nakajima T; Egawa E; Kuruma I
    Jpn J Pharmacol; 1981 Apr; 31(2):159-64. PubMed ID: 6118446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
    Rothblat DS; Schneider JS
    Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the ability of some neuroleptics to enhance striatal [3H]dopamine release and their lipophilicity.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1983 Aug; 32(16):2411-6. PubMed ID: 6137221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slices.
    Kerwin RW; Rupniak NM; Jenner P; Marsden CD
    Neuroscience; 1984 Jan; 11(1):205-10. PubMed ID: 6143281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons.
    Wood PL; McQuade PS; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):765-8. PubMed ID: 6141617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug.
    Severson JA; Robinson HE; Simpson GM
    Psychopharmacology (Berl); 1984; 84(1):115-9. PubMed ID: 6149590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
    Korpi ER; Wyatt RJ
    Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
    Dismukes K; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Des-1-tyrosine-gamma-endorphin: an assessment of its neuroleptic properties and effect on dopamine synthesis].
    Raevskiĭ KS; Shemanov AIu; Kudrin VS
    Farmakol Toksikol; 1982; 45(5):5-8. PubMed ID: 6128254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
    Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum.
    de Belleroche JS; Neal MJ
    Neuropharmacology; 1982 Jun; 21(6):529-37. PubMed ID: 6125910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure.
    Schmidt MH; Lee T
    Psychiatry Res; 1991 Mar; 36(3):319-28. PubMed ID: 1676523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex.
    Arbilla S; Briley MS; Dubocovich ML; Langer SZ
    Life Sci; 1978 Oct; 23(17-18):1775-80. PubMed ID: 31532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.